Reactive oxygen species nanoamplifiers with multi-enzymatic activities for enhanced tumor therapy
Nanoscale · 2023
DOI: 10.1039/d3nr00107e ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanoscale, 2023. Verfasst von Shasha Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Education Ministry Key Lab of Resource Chemistry, Joint International Research Laboratory of Resource Chemistry, Ministry of Education, Shanghai …. Hauptthemen laut MEDLINE: Hereditary Sensory and Motor Neuropathy, Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai, Shanghai Normal University, National Natural Science Foundation of China.
Abstract (Originalsprache)
The multi-enzyme activities of Ce-doped carriers combined with saikosaponin A effectively inhibit tumor growth by amplifying oxidative stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Education Ministry Key Lab of Resource Chemistry, Joint International Research Laboratory of Resource Chemistry, Ministry of Education, Shanghai Key Laboratory of Rare Earth Functional Materials, Shanghai Municipal…
Förderung
- Natural Science Foundation of Shanghai
- Shanghai Normal University
- National Natural Science Foundation of China
Zitieren
APA
Zhao, S., Lai, K., Gao, Z., Ye, X., Mou, J., Yang, S., & Wu, H. (2023). Reactive oxygen species nanoamplifiers with multi-enzymatic activities for enhanced tumor therapy. Nanoscale. https://doi.org/10.1039/d3nr00107e
Vancouver
Zhao S, Lai K, Gao Z, Ye X, Mou J, Yang S, et al. Reactive oxygen species nanoamplifiers with multi-enzymatic activities for enhanced tumor therapy. Nanoscale. 2023. doi:10.1039/d3nr00107e
BibTeX
@article{Zhao2023,
author = {Zhao, Shasha and Lai, Kexin and Gao, Zhen and Ye, Xueli and Mou, Juan and Yang, Shiping and Wu, Huixia},
title = {Reactive oxygen species nanoamplifiers with multi-enzymatic activities for enhanced tumor therapy},
journal = {Nanoscale},
year = {2023},
doi = {10.1039/d3nr00107e}
}
EUVIMED